COVID-19 vaccines: authorised
16. Dezember 2022 – The EMA published the assessment report for Spikevax supporting its use as a booster in adolescents aged 12 to 18.
For more information, see here.
16. Dezember 2022 – The EMA published the assessment report for Spikevax supporting its use as a booster in adolescents aged 12 to 18.
For more information, see here.